Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Life Technologies Rejected by Supreme Court, Allowing Enzo Suit

By Greg Stohr

June 20 (Bloomberg) -- The U.S. Supreme Court refused to hear an appeal by Life Technologies Corp., letting Enzo Biochem Inc. press ahead with a patent infringement suit over a way to detect genetic sequences and diagnose human diseases, including cancer.

The justices today left intact a federal appeals court ruling that revived two Enzo patents invalidated by a trial court. Life Technologies and its Applera unit argued unsuccessfully that the patents weren’t specific enough in their description of the claimed invention.

Life Technologies, based in Carlsbad, California, has said the two patents are expired, so the lawsuit won’t have any effect on current products. New York-based Enzo and Yale University are seeking royalties in their lawsuit.

The case is Applera v. Enzo Biochem, 10-426.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.